Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
JPEN J Parenter Enteral Nutr ; 19(3): 244-7, 1995.
Article in English | MEDLINE | ID: mdl-8551656

ABSTRACT

BACKGROUND: The provision of early postoperative enteral feeding may be enhanced by the placement of enteral feeding access during celiotomy, but surgeons are often reluctant to pursue this option because of the extra effort required. METHODS: We conducted a retrospective review of our 2-year experience with 60 sequential intraoperative nasoenteric feeding-tube placements and included data on demographics, diagnosis, surgery, type of feeding tube, formula, tolerance, and complications. Our surgeons placed intraoperative nasoenteric feeding tubes at their discretion in a variety of subjects who were undergoing elective or urgent celiotomies. RESULTS: The surgeries largely involved the upper gastrointestinal tract, and feeding-tube placements were readily accomplished. The majority of patients received enteral feedings within 3 postoperative days and achieved feeding rates of 50 mL/h or greater. The average duration of feeding-tube use was 1 week, accounting for 399 feeding days overall. There were no serious complications attributable to feeding-tube placement or use, but inadvertent tube removal by patients or staff was a limitation. CONCLUSIONS: Intraoperative placement of the nasoenteric feeding tube may be a reasonable option for treating the surgical patient at nutritional risk who faces a limited course of impaired oral intake postoperatively.


Subject(s)
Digestive System Surgical Procedures , Enteral Nutrition , Intubation, Gastrointestinal/methods , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Intraoperative Period , Intubation, Gastrointestinal/adverse effects , Male , Middle Aged , Retrospective Studies , Time Factors
2.
Am J Clin Nutr ; 60(4): 518-24, 1994 Oct.
Article in English | MEDLINE | ID: mdl-8092086

ABSTRACT

The lymphatic absorption of a structured triacylglycerol vs an equivalent physical mixture of the constituent medium-chain triacylglycerol and fish oils was studied. Each of four canines served as its own control in a crossover feeding design with the investigators unaware of diet contents. Lymphatic absorption of n-3 and medium-chain fatty acids peaked within 4-8 h of feeding either diet. The lymph contained more 10:0 fatty acids than 8:0 despite an overall ratio of 10:0 to 8:0 of 0.3 for the diets. The mass of medium-chain fatty acids absorbed in the lymph at measured time points was 2.6 +/- 0.5-fold higher (mean +/- SE of 12 determinations) for the structured triacylglycerol compared with the physical mix. Molecular species analyses revealed that the medium-chain fatty acids in lymph were present as mixed triacylglycerols. The unique molecular structure of these mixed triacylglycerols and the fatty acids at the 2-position may account for the improved absorption.


Subject(s)
Enteral Nutrition , Lymphatic System/metabolism , Triglycerides/administration & dosage , Triglycerides/metabolism , Absorption , Animals , Dogs , Fatty Acids/analysis , Fatty Acids/chemistry , Fatty Acids/metabolism , Kinetics , Triglycerides/analysis
4.
Gynecol Oncol ; 41(2): 149-51, 1991 May.
Article in English | MEDLINE | ID: mdl-1646758

ABSTRACT

A case of a 29-year-old woman with primary small cell carcinoma of the ovary associated with hypercalcemia is presented. Despite intensive surgical and chemotherapeutic intervention, the patient expired after 19 months. Literature review indicates that this rare tumor grows rapidly, with hypercalcemia occurring frequently. Absence of effective treatment results in early mortality.


Subject(s)
Carcinoma, Small Cell/pathology , Ovarian Neoplasms/pathology , Adult , Antineoplastic Agents/therapeutic use , Bone Marrow Transplantation , Breast Neoplasms/secondary , Carcinoma, Small Cell/secondary , Carcinoma, Small Cell/surgery , Combined Modality Therapy , Female , Humans , Hypercalcemia/complications , Lung Neoplasms/secondary
6.
Postgrad Med ; 85(7): 79-80, 84, 1989 May 15.
Article in English | MEDLINE | ID: mdl-2717509

ABSTRACT

Fatal hemolytic anemia occurred in a 71-year-old man after trimethoprim-sulfamethoxazole was given for presumed cystitis. Administration of this combination has previously caused multiple hematologic reactions by affecting folic acid metabolism. Megaloblastic anemia and neutropenia have been produced by both of these agents, while sulfamethoxazole alone has induced acute hemolytic anemia in patients with hereditary deficiency of glucose-6-phosphate dehydrogenase. Although hematologic complications of trimethoprim-sulfamethoxazole treatment usually follow long-term or high-dose therapy, acute reactions apparently may occur at lower doses as well.


Subject(s)
Anemia, Hemolytic/chemically induced , Drug Hypersensitivity/etiology , Sulfamethizole/adverse effects , Sulfathiazoles/adverse effects , Trimethoprim/adverse effects , Aged , Cause of Death , Drug Combinations/adverse effects , Humans , Male
7.
Hastings Cent Rep ; 18(5): 34-6, 1988.
Article in English | MEDLINE | ID: mdl-3225190

ABSTRACT

KIE: Two commentaries explore the question of how much information should be disclosed to a 16-year-old female patient about the genetic abnormality, testicular feminization (XY genotype), which renders her infertile. She has presented with precancerous testes that require surgical removal and also needs an operation on her vagina in order for her to be able to engage in intercourse. Minoque and Taraszewski argue that full disclosure creates no significant benefit to the patient's freedom to act in accordance with what she considers her own best interest, so that the physician has no obligation to convey the genetic information to the patient or to her parents. Elias and Annas contend that everyone's best interests will be best served only by a full explanation of the syndrome and of the risks and benefits of the suggested surgery for consent to the surgery to be informed.^ieng


Subject(s)
Androgen-Insensitivity Syndrome/genetics , Genetic Diseases, Inborn , Informed Consent/legislation & jurisprudence , Truth Disclosure , Adolescent , Androgen-Insensitivity Syndrome/psychology , Gender Identity , Humans , Male , Moral Obligations , Parental Consent , Paternalism , Risk Assessment
8.
J Clin Pharmacol ; 27(12): 980-2, 1987 Dec.
Article in English | MEDLINE | ID: mdl-3325531

ABSTRACT

A year-long double-blind cross-over study was used to compare the long-term therapeutic effects of lithium versus verapamil in a group of 20 manic volunteers. Subjects received each medication for six months. Before cross-over, verapamil patients showed a significant improvement after 60 days, lithium-treated patients after 180 days. After cross-over, verapamil-treated subjects showed improvement at day 240. Lithium-treated patients showed no improvement after cross-over. The data indicate that verapamil may be effective as an agent in the maintenance treatment of manic patients.


Subject(s)
Bipolar Disorder/drug therapy , Lithium/therapeutic use , Verapamil/therapeutic use , Adult , Bipolar Disorder/psychology , Clinical Trials as Topic , Double-Blind Method , Humans , Male , Psychiatric Status Rating Scales , Random Allocation
SELECTION OF CITATIONS
SEARCH DETAIL
...